Clinical Perspectives in Perfusion: Neuroradiologic Applications

Topics in Magnetic Resonance Imaging

Volumn 15, Issue 1, 2004, Pages 28-40

  Rowley, Howard A ^a   Roberts, Timothy P L ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Magnetic resonance imaging; Perfusion; Stroke

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; HUMAN; IMAGING; NEURORADIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; VASCULAR DISEASE;

BLOOD VOLUME; BRAIN ISCHEMIA; BRAIN NEOPLASMS; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; ECHO-PLANAR IMAGING; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING;

EID: 1842511479     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200402000-00004     Document Type: Review

References (66)

1. Jezzard P. Advances in perfusion MR imaging. Radiology. 1998;208:296-299.
2. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin North Am. 1999;9:309-331.
3. Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol. 2000;175:207-219.
4. Keston P, Murray AD, et al. Cerebral perfusion imaging using contrast-enhanced MRI. Clin Radiol. 2003;58:505-513.
5. Sorensen AG, Reimer P. Cerebral MR Prfusion Imaging: Principles and Current Applications. Stuttgart, Germany: Thieme, 2000.
6. Runge VM, Knopp MV. Off-label use and reimbursement of contrast media in MR. J Magn Reson Imaging. 1999;10:489-495.
7. Latchaw RE, Yonas H, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke. 2003;34:1084-1104.
8. Sorensen AG, Tievsky AL, et al. Contrast agents in functional MR imaging. J Magn Reson Imaging. 1997;7:47-55.
9. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 2000;12:205-213.
10. Joffe P, Thomsen HS, et al. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol. 1998;5:491-502.
11. Benner T, Reimer P, et al. Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a doubleblinded randomized dose-finding study. J Magn Reson Imaging. 2000;12:371-380.
12. Carroll TJ, Rowley HA, et al. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology. 2003;227:593-600.
13. Warach S. Measurement of the ischemic penumbra with MRI: it's about time. Stroke. 2003;34:2533-2534.
14. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology. 1999;52:1750-1756.
15. Heiss WD, Thiel A, et al. Which targets are relevant for therapy of acute ischemic stroke? Stroke. 1999;30:1486-1489.
16. van Zijl PC, Eleff SM, et al. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med. 1998;4:159-167.
17. Warach S, Li W, et al. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology. 1992;182:41-47.
18. Schlaug G, Benfield A, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
19. Tong DC, Yenari MA, et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
20. Sunshine JL, Tarr RW, et al. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology. 1999;212:325-332.
21. Grandin CB, Duprez TP, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology. 2002;223:361-370.
22. Sorensen AG, Copen WA, et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology. 1999;210:519-527.
23. Rohl L, Ostergaard L, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001;32:1140-1146.
24. Hermier M, Nighoghossian N, et al. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke. J Cereb Blood Flow Metab. 2003;23:240-248.
25. Schaefer PW, Ozsunar Y, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol. 2003;24:436-443.
26. Ostergaard L, Sorensen AG, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke. 2000;31:1097-1103.
27. Simonsen CZ, Rohl L, et al. Final infarct size after acute stroke: prediction with flow heterogeneity. Radiology. 2002;225:269-275.
28. van Osch MJ, Vonken EJ, et al. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med. 2001;45:477-485.
29. Yamada K, Wu O, et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke. 2002;33:87-94.
30. Kao YH, Guo WY, et al. Hemodynamic segmentation of MR brain perfusion images using independent component analysis, thresholding, and Bayesian estimation. Magn Reson Med. 2003;49:885-894.
31. Wu O, Ostergaard L, et al. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med. 2003;50:164-174.
32. Hacke W. The DIAS Study: Results of a Phase II, MRI-Based Dose Finding Study of Desmoteplase in Acute Stroke. San Diego, CA: American Stroke Association, American Heart Association, 2004.
33. Warach S. Early Reperfusion Related to Clinical Response in DIAS: Phase II, Randomized, Placebo-Controlled Dose Finding Trial of IV Desmoteplase 3-9 Hours From Onset in Patients With Diffusion-Perfusion Mismatch. San Diego, CA: American Stroke Association, American Heart Association, 2004.
34. Derdeyn CP, Grubb RL Jr, et al. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251-259.
35. Derdeyn CP. Physiological neuroimaging: emerging clinical applications. JAMA. 2001;285:3065-3068.
36. Derdeyn CP, Khosla A, et al. Severe hemodynamic impairment and border zone-region infarction. Radiology. 2001;220:195-201.
37. Derdeyn CP, Videen TO, et al. Comparison of PET oxygen extraction fraction methods for the prediction of stroke risk. J Nucl Med. 2001;42:1195-1197.
38. Derdeyn CP, Videen TO, et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595-607.
39. Derdeyn CP, Grubb RL Jr, et al. Re: Stages and thresholds of hemodynamic failure. Stroke. 2003;34:589.
40. Detre JA, Alsop DC. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol. 1999;30:115-124.
41. O'Sullivan M, Lythgoe DJ, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321-326.
42. Neumann-Haefelin T, Wittsack HJ, et al. Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. Stroke. 2000;31:1311-1317.
43. Kuge Y, Yokota C, et al. Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke. J Cereb Blood Flow Metab. 2001;21:202-210.
44. Marks MP, Tong DC, et al. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology. 1999;52:1792-1798.
45. Kidwell CS, Saver JL, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology. 2001;57:2015-2021.
46. Molina CA, Alvarez-Sabin J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002;33:1551-1556.
47. Infeld B, Davis SM, et al. Streptokinase increases luxury perfusion after stroke. Stroke. 1996;27:1524-1529.
48. Barber PA, Davis SM, et al. Spontaneous reperfusion after ischemic stroke is associated with improved outcome. Stroke. 1998;29:2522-2528.
49. Maeda M, Itoh S, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology. 1993;189:233-238.
50. Siegal T, Rubinstein R, et al. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg. 1997;86:22-27.
51. Cha S, Knopp EA, et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol. 2000;21:881-890.
52. Henry RG, Vigneron DB, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol. 2000;21:357-366.
53. Wong JC, Provenzale JM, et al. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol. 2000;174:1147-1157.
54. Wetzel SG, Cha S, et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: a comparative study with DSA. AJNR Am J Neuroradiol. 2002;23:1767-1774.
55. Law M, Yang S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989-1998.
56. Cha S, Knopp EA, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11-29.
57. Law M, Cha S, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology. 2002;222:715-721.
58. Provenzale JM, Wang GR, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol. 2002;178:711-716.
59. Yang D, Korogi Y, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology. 2002;44:656-666.
60. Roberts HC, Roberts TP, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21:891-899.
61. Yang S, Law M, et al. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol. 2003;24:1554-1559
62. Essig M, Waschkies M, et al. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology. 2003;228:193-199.
63. Cha S, Pierce S, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2001;22:1109-1116.
64. Engelter ST, Petrella JR, et al. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol. 1999;173:1491-1493.
65. Cutrer FM, Sorensen AG, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998;43:25-31.
66. Masuzaki M, Utsunomiya H, et al. A case of hemiplegic migraine in childhood: transient unilateral hyperperfusion revealed by perfusion MR imaging and MR angiography. AJNR Am J Neuroradiol. 2001;22:1795-1797.